Table 4 Univariate and multivariate analysis for risk factors for relapse

From: Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

Valuables

Univariate analysis

Multivariate analysis

p-Value

Hazard ratio

p-Value

Disease status

0.887

–

–

Treatment center

0.684

–

–

Cycles of chemo

0.640

–

–

Donor type

0.255

–

–

Bone marrow blast

0.314

6.88 (0.741, 63.899)

0.090

Age

0.032

1.06 (1.013, 1.109)

0.012

Back to article page